Lung cancer showdown: surgery vs. radiation in High-Risk patients
NCT ID NCT07432802
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two treatments for high-risk patients with early-stage non-small cell lung cancer: minimally invasive surgery (wedge resection) and stereotactic body radiation therapy (SBRT). The goal is to see which approach leads to longer disease-free survival and better quality of life. The trial will enroll 182 participants across Denmark and follow them for up to 5 years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Stereotactic body radiation therapy (SBRT) or minimally invasive wedge resection surgery
What this could lead to
If this trial succeeds, it could provide clear evidence on whether radiation or surgery is better for controlling early-stage lung cancer in high-risk patients, helping doctors make more informed treatment decisions.
What could go wrong
This trial is not yet recruiting and has a relatively small size (182 participants). Results may not apply to all patients, and both treatments carry risks like complications from surgery or side effects from radiation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aalborg University Hospital
Aalborg, Aalborg, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Aarhus University Hospital
Aarhus N, 8200, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Odense University Hospital
Odense, 5000, Denmark
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
-
Rigshospitalet
Copenhagen, Copenhagen, 2100, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact